Publications

RARE TUMOURS

Authors: E Panosyan, M Gotesman, T Kallay, S Martinez, M Bolaris, J Lasky, F Fouyssa...

Research group: Gilbertson Group

E-pub date: 1 Jun 2014

Journal name: Neuro-Oncology

TUMOUR BIOLOGY

Authors: T Geller, V Prakash, J Batanian, M Guzman, E Duncavage, T Gershon, A Crowth...

Research group: Gilbertson Group

E-pub date: 1 Jun 2014

Journal name: Neuro-Oncology

EPENDYMOMA

Authors: LM Hoffman, AM Donson, I Nakachi, AM Griesinger, DK Birks, V Amani, MS Heme...

Research group: Gilbertson Group

E-pub date: 1 Jun 2014

Journal name: Neuro-Oncology

MEDULLOBLASTOMA

Authors: G Vaidyanathan, S Gururangan, D Bigner, M Zalutsky, M Morfouace, A Shelat, ...

Research group: Gilbertson Group

E-pub date: 1 Jun 2014

Journal name: Neuro-Oncology

Addendum: Quantitative sequencing of 5-formylcytosine in DNA at single-base resolution.

Authors: MJ Booth, G Marsico, M Bachman, D Beraldi, S Balasubramanian

Research group: Balasubramanian Group

E-pub date: 21 May 2014

Journal name: Nat Chem

ARIEL 2/3: An integrated clinical trial program to assess activity of rucaparib in ovarian cancer and to identify tumor molecular characteristics predictive of response.

Authors: EM Swisher, IA McNeish, RL Coleman, J Brenton, SH Kaufmann, AR Allen, M Rap...

Research group: Brenton Group

E-pub date: 20 May 2014

Journal name: Journal of Clinical Oncology

A national platform for molecular diagnostics: Results of the Cancer Research U.K. Stratified Medicine Programme.

Authors: E Shaw, R Butler, D Gonzalez de Castro, M Griffiths, A Hanby, J Hair, F Rae...

Research group: Brenton Group

E-pub date: 20 May 2014

Journal name: Journal of Clinical Oncology

ICON8: An international randomized trial comparing two dose-dense regimens, 3-weekly carboplatin plus weekly paclitaxel (CwT), and weekly carboplatin-paclitaxel (wCwT), to standard 3-weekly treatment in women with newly diagnosed ovarian, fallopian tube, and primary peritoneal cancer.

Authors: J Hook, SP Stenning, J Brenton, SB Kaye, IA McNeish, R Naik, T Perren, J Pe...

Research group: Brenton Group

E-pub date: 20 May 2014

Journal name: Journal of Clinical Oncology

Filters

Research Groups

Core Facilities

Start date

End date

RARE TUMOURS

TUMOUR BIOLOGY

EPENDYMOMA

MEDULLOBLASTOMA

Addendum: Quantitative sequencing of 5-formylcytosine in DNA at single-base resolution.

ARIEL 2/3: An integrated clinical trial program to assess activity of rucaparib in ovarian cancer and to identify tumor molecular characteristics predictive of response.

A national platform for molecular diagnostics: Results of the Cancer Research U.K. Stratified Medicine Programme.

ICON8: An international randomized trial comparing two dose-dense regimens, 3-weekly carboplatin plus weekly paclitaxel (CwT), and weekly carboplatin-paclitaxel (wCwT), to standard 3-weekly treatment in women with newly diagnosed ovarian, fallopian tube, and primary peritoneal cancer.

Themes

Filters

Research Groups

Core Facilities

Start date

End date

RARE TUMOURS

TUMOUR BIOLOGY

EPENDYMOMA

MEDULLOBLASTOMA

Addendum: Quantitative sequencing of 5-formylcytosine in DNA at single-base resolution.

ARIEL 2/3: An integrated clinical trial program to assess activity of rucaparib in ovarian cancer and to identify tumor molecular characteristics predictive of response.

A national platform for molecular diagnostics: Results of the Cancer Research U.K. Stratified Medicine Programme.

ICON8: An international randomized trial comparing two dose-dense regimens, 3-weekly carboplatin plus weekly paclitaxel (CwT), and weekly carboplatin-paclitaxel (wCwT), to standard 3-weekly treatment in women with newly diagnosed ovarian, fallopian tube, and primary peritoneal cancer.